Peptide stacking has potential in regenerative and longevity medicine, but using unregulated or poorly studied peptides is ...

TB-500 (a fragment of Thymosin Beta-4) and BPC-157 (Body Protection Compound) are two naturally derived peptide chains that have been the subject of significant academic interest. Each has been ...

Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15 ...

Celent has named BPC, a global leader in payment solutions, a Luminary, Celent’s highest designation, in a new research report, “Retail Digital Banking Platforms: Latin America Edition, 2025” ...

October 31, 2025-- Orlando, FL — Core Peptides has announced expanded availability of its dual-peptide formulation TB-500 and BPC-157, a complementary pairing recognized in peptide science for its ...